Clinical Trial Update: Optimized Treatment and Regression of HBV-induced Liver Fibrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed that reports optimized treatment associated with regression of HBV-induced liver fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Liver Fibrosis | Phase 4 | Status: COMPLETED